Status | Study |
Active, not recruiting |
Study Name: Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia Condition: Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Recur Date: 2012-01-16 Interventions: Drug: Dinaciclib Given IV |
Terminated |
Study Name: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia Condition: B-cell Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Date: 2010-05-18 Interventions: Drug: alvespimycin hydrochloride |
Active, not recruiting |
Study Name: Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies Condition: Leukemia Date: 2010-03-25 Interventions: Drug: Nelarabine Starting dose 200 mg/m2 for 5 day continuous infusion administered via a central cathet |
Recruiting |
Study Name: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Condition: B-Cell Prolymphocytic Leukemia Hypodiploidy Date: 2009-11-04 Interventions: Procedure: Allogeneic Bone Marrow Transplantation |
Active, not recruiting |
Study Name: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Condition: B-Cell Prolymphocytic Leukemia Chronic Lymphocytic Leukemia Date: 2003-05-06 Interventions: Drug: Cyclosporine Given PO |